Leadership Overview
LifeNet Health has 5 executives leading key functions including operations, financial management, human resources, technology development, and organizational strategy.
Committed to advancing regenerative medicine, LifeNet Health delivers innovative transplantation solutions and cellular therapies to improve patient outcomes globally through rigorous quality standards and medical research.
Committed to advancing regenerative medicine, LifeNet Health delivers innovative transplantation solutions and cellular therapies to improve patient outcomes globally through rigorous quality standards and medical research.
Leadership Roles at LifeNet Health
Philip Jones - Chief Financial Officer
Philip Jones, the Chief Financial Officer at LifeNet Health, manages the fiscal health and long-term capital allocation for the organization. Overseeing the financial planning and analysis departments, the Chief Financial Officer ensures that resources remain directed toward high-impact research and development initiatives. Jones monitors global market trends to maintain the financial stability required for nonprofit operations in the medical sector. By evaluating investment opportunities in transplantation technology, the Chief Financial Officer supports the expansion of regenerative therapy programs. Philip Jones coordinates with executive leadership to balance budgetary constraints with the mission of enhancing patient outcomes. This role involves rigorous oversight of audit processes and regulatory compliance to protect the integrity of the organization. Through strategic financial modeling, the Chief Financial Officer enables the scaling of tissue donation services across diverse healthcare networks. Ultimately, Jones provides the economic framework necessary for the continued advancement of medical innovation.
Alan Bortnick - Chief Operating Officer
Alan Bortnick, the Chief Operating Officer at LifeNet Health, directs all internal logistics and tissue processing workflows. Overseeing the daily execution of transplantation services, the Chief Operating Officer ensures that every regenerative medicine product meets stringent safety benchmarks. Bortnick manages the complex supply chain infrastructure required to support healthcare providers across North American markets. By optimizing operational efficiency, the Chief Operating Officer facilitates the seamless delivery of life-saving cellular solutions to clinical partners. Alan Bortnick maintains constant alignment with the board to scale production capabilities in response to rising medical demand. This leadership role involves streamlining cross-departmental communication to reduce processing times for critical organ donation services. Through the implementation of advanced manufacturing protocols, the Chief Operating Officer drives the organization toward higher standards of excellence. Ultimately, Bortnick secures the operational foundation necessary for sustained growth in the competitive field of regenerative medicine.
Pam Goldschmidt - President
Pam Goldschmidt, the President at LifeNet Health, directs the overarching strategic vision and mission-driven initiatives of the organization. Overseeing the alignment of all departments with the goal of advancing regenerative medicine, the President ensures that transplantation services reach patients in need across global markets. Goldschmidt manages relationships with key stakeholders and healthcare providers to expand the reach of life-saving therapies. By setting the long-term agenda for growth and innovation, the President guides the executive team toward achieving superior patient outcomes. Pam Goldschmidt fosters a collaborative environment where research, operations, and finance work in unison to support the nonprofit mission. This leadership role involves representing the organization in public forums and industry conferences to promote the benefits of tissue and organ donation. Through decisive leadership, the President drives the organization to maintain its status as a pioneer in medical technology. Ultimately, Goldschmidt ensures the continued impact of the organization on the global healthcare landscape.
James Bibbs - Chief Human Resources Officer
James Bibbs, the Chief Human Resources Officer at LifeNet Health, directs the talent acquisition and organizational development strategies. Overseeing the recruitment of specialized medical professionals, the Chief Human Resources Officer ensures that the workforce possesses the expertise required for complex regenerative medicine tasks. Bibbs manages employee engagement programs to foster a culture of innovation and clinical excellence. By implementing comprehensive training initiatives, the Chief Human Resources Officer aligns staff capabilities with the evolving needs of the transplantation industry. James Bibbs collaborates with other executives to design performance management systems that reward contributions to patient care. This leadership role involves maintaining high retention rates among researchers and clinical staff through competitive benefits and professional growth opportunities. Through the cultivation of a skilled workforce, the Chief Human Resources Officer supports the mission of delivering life-saving therapies. Ultimately, Bibbs strengthens the human capital foundation essential for the long-term success of the organization.
Kelvin Brockbank - Chief Technology Officer (Charleston)
Kelvin Brockbank, the Chief Technology Officer (Charleston) at LifeNet Health, architects the technical infrastructure for cellular research and development. Overseeing the integration of cutting-edge medical technology, the Chief Technology Officer (Charleston) ensures that laboratory processes remain at the forefront of regenerative medicine. Brockbank drives the innovation pipeline by identifying emerging scientific trends that enhance transplantation outcomes. By managing the technical teams responsible for tissue engineering, the Chief Technology Officer (Charleston) facilitates the transition from research to clinical application. Kelvin Brockbank coordinates with external research partners to validate new therapeutic solutions. This leadership role involves maintaining rigorous quality control over all technological assets and digital systems used in medical procedures. Through the application of advanced engineering principles, the Chief Technology Officer (Charleston) optimizes the development of proprietary cellular solutions. Ultimately, Brockbank secures the technical edge required to maintain the organization's position as a leader in the medical manufacturing industry.
Explore Leadership Teams in Manufacturing
Dental Implant & Denture Laboratory in Staten Island, New York At our laboratory, we work with you and your patients as a team. Let us help you successfully complete your dental implant cases. Our dental consultants discuss the specifics of any case with you. Ask us about our complete denture services today. We make traditional dentures and partials, and we offer additional dentures at additional cost. With a strong commitment to the dental professional, we offer several dental seminars. We want to keep our customers educated on the current trends and technology. Contact us today in Staten Island, New York , when you need services from a dental implant and denture laboratory you can trust. With more than 40 years of experience, the staff at our dental implant and denture laboratory in Staten Island, New York, is a select group of technicians experienced in implant dentistry. Since 1985, Specialized Dental Implants & Restoration has been committed to your success. We offer a large variety of options and we have the knowledge and experience to achieve long-term predictable results. We are committed to returning your work on a timely schedule, and we accept most leading major credit cards for your convenience. Check back frequently for more information on how we can benefit your practice by providing quality restorations that add value to your service.
Company Leadership SH
RG
DS
RR
Integer® Holdings Corporation (NYSE:ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, vascular and portable medical markets. The company provides innovative, high-quality technologies and manufacturing to Medical Device OEMs to enhance the lives of patients worldwide. In addition, it develops batteries for high-end niche applications in energy, military, and environmental markets. Greatbatch Medical®, Lake Region Medical® and Electrochem® comprise the companys brands. Our story is one filled with 80 years of industry-changing innovations and exemplary manufacturing. Its a legacy we are proud of as we continue to provide customers with unparalleled expertise, innovation and manufacturing excellence. We are guided by our values of Innovation, Collaboration, Inclusion, Candor, Integrity and Customer.
Company Leadership
SS
JF

ESTABLISHMENT LABS HOLDINGS INC. (NASDAQ:ESTA) is a global medical technology company dedicated to improving women’s health and wellness through the power of science, engineering, and technology. The Company offers a portfolio of Femtech solutions for breast health, breast aesthetics and breast reconstruction. The Motiva Flora® tissue expander is the only regulatory-approved expander in the world with an integrated port that is MRI conditional and is used to improve outcomes in breast reconstruction following breast cancer. Mia Femtech, Establishment Lab’s unique minimally invasive experience for breast harmony, is the Company’s most recent breakthrough innovation. These solutions are supported by over 200 patent applications in 25 separate patent families worldwide and over 50 scientific studies and publications in peer-reviewed journals.
Company Leadership



Lumenis Ltd. is a company that develops and commercializes energy-based technologies for skin, body, and eye care treatments. It provides trilift, optilight, stellar M22, optiplus, and digital duet. The company was founded in 1966 and is based in Hesse, Germany.
Company Leadership MK
MU
JT
TB